[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Suwalsky et al., 2006 - Google Patents

Effects of the antiepileptic drug carbamazepine on human erythrocytes

Suwalsky et al., 2006

View PDF
Document ID
13840720437995802817
Author
Suwalsky M
Mennickent S
Norris B
Villena F
Sotomayor C
Publication year
Publication venue
Toxicology in vitro

External Links

Snippet

The structural effects of the antiepileptic drug carbamazepine (CBZ) on the human erythrocyte membrane and molecular models have been investigated in the present work. This report presents the following evidence that CBZ interacts with red cell membranes:(a) X …
Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Similar Documents

Publication Publication Date Title
Richards et al. Two modes of exocytosis at hippocampal synapses revealed by rate of FM1-43 efflux from individual vesicles
Verkman Mechanisms and regulation of water permeability in renal epithelia
Betz et al. Conformational change of membrane proteins leads to shape changes of red blood cells
Silverman Glucose transport in the kidney
Saotome et al. Mitochondrial membrane potential modulates regulation of mitochondrial Ca2+ in rat ventricular myocytes
Suwalsky et al. Effects of the antiepileptic drug carbamazepine on human erythrocytes
Suwalsky et al. Acetylsalicylic acid (aspirin) and salicylic acid interaction with the human erythrocyte membrane bilayer induce in vitro changes in the morphology of erythrocytes
Marczak Fluorescence anisotropy of membrane fluidity probes in human erythrocytes incubated with anthracyclines and glutaraldehyde
Suwalsky et al. Interactions of the antiviral and antiparkinson agent amantadine with lipid membranes and human erythrocytes
Rodrigues et al. The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin‐permeabilization
Rojas-Aguirre et al. Effects of an antimalarial quinazoline derivative on human erythrocytes and on cell membrane molecular models
Suwalsky et al. An in vitro study on the antioxidant capacity of usnic acid on human erythrocytes and molecular models of its membrane
Vadhana et al. Perturbation of rat heart plasma membrane fluidity due to metabolites of permethrin insecticide
Gan et al. Loading pyranine via purinergic receptors or hypotonic stress for measurement of cytosolic pH by imaging
Leonard et al. Tuning of differential lipid order between submicrometric domains and surrounding membrane upon erythrocyte reshaping
Suwalsky et al. Cadmium-induced changes in the membrane of human erythrocytes and molecular models
Suwalsky et al. Human cells and cell membrane molecular models are affected in vitro by chlorpromazine
Suwalsky et al. HgCl2 disrupts the structure of the human erythrocyte membrane and model phospholipid bilayers
Reinhart et al. Interaction of injectable neurotropic drugs with the red cell membrane
Suwalsky et al. Effects of lead on the human erythrocyte membrane and molecular models
Ramos et al. Prevalence of necrosis in C2-ceramide–induced cytotoxicity in NB16 neuroblastoma cells
Suwalsky et al. Interactions of Al (acac) 3 with cell membranes and model phospholipid bilayers
Cecchi et al. Differentiation increases the resistance of neuronal cells to amyloid toxicity
Bonomini et al. Interactions between platelets and leukocytes during hemodialysis
Suwalsky et al. Effects of lithium on the human erythrocyte membrane and molecular models